Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Sell
28,959
-16,446
-36% -$997K 0.03% 430
2025
Q4
$2.89M Sell
45,405
-7,130
-14% -$465K 0.06% 274
2025
Q3
$3.66M Buy
52,535
+8,667
+20% +$646K 0.12% 184
2025
Q2
$3.12M Buy
43,868
+29,404
+203% +$1.77M 0.1% 215
2025
Q1
$918K Sell
14,464
-10,747
-43% -$791K 0.07% 228
2024
Q4
$1.91M Buy
25,211
+21,079
+510% +$1.66M 0.12% 161
2024
Q3
$365K Buy
+4,132
New +$324K 0.06% 125
2023
Q2
Sell
-2,134
Closed -$262K 142
2023
Q1
$262K Buy
+2,134
New +$262K 0.06% 140

Other funds holding NKE

Callan Family Office's NKE Position: Q1 2026 in Review

Callan Family Office reduced its Nike (NKE) stake by 36% in Q1 2026, selling an estimated $997K and leaving 28,959 shares worth $1.53M. The position accounts for 0.03% of the portfolio, ranked #430.

Callan Family Office first reported a position in NKE in Q1 2023 and has held it in 8 quarters since. The position peaked at $3.66M in Q3 2025. 1,912 funds tracked by Wall St. Rank hold NKE as of Q1 2026.

  • Callan Family Office held 28,959 shares of Nike worth $1.53M as of Q1 2026.
  • Callan Family Office sold 16,446 Nike shares in Q1 2026, an estimated $997K.
  • Nike made up 0.03% of Callan Family Office's portfolio in Q1 2026, its #430 holding.
  • Callan Family Office first reported a position in Nike in Q1 2023 and has held it in 8 quarters since.
  • Callan Family Office's Nike position peaked at $3.66M in Q3 2025.
  • 1,912 funds tracked by Wall St. Rank held Nike as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.